Day One Biopharmaceuticals

Day One Biopharmaceuticals is one of the...

• Russell 3000.

Day One Biopharmaceuticals is a company listed under the stock ticker DAWN (US).

View the org chart displaying its 34 main executives

Most searched biographies at Day One Biopharmaceuticals

• Jeremy Bender, Chief Executive Officer and Director
• Michael Gladstone, Director
• John Josey, Director

Popular executive movements at Day One Biopharmaceuticals

• William Grossman has joined the company as Director  (posted on January 18 2024).
• Habib Dable has joined the company as Director  (posted on January 18 2024).

Create your alert
to follow the executive moves at Day One Biopharmaceuticals.

Day One Biopharmaceuticals has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Day One Biopharmaceuticals

• Day One Reports Third Quarter 2023 Financial Results and Corporate Progress | Day One Biopharmaceuticals, Inc.
• Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) | Day One Biopharmaceuticals, Inc.
• Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG) | Day One Biopharmaceuticals, Inc.
• Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience | Day One Biopharmaceuticals, Inc.
• Day One Reports Second Quarter 2023 Financial Results and Corporate Progress | Day One Biopharmaceuticals, Inc.
• About – DayOne
• View more press releases Close

Social media about Day One Biopharmaceuticals

• Day One Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Day One Biopharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Jeremy Bender

Call Day One Biopharmaceuticals at +1 650...

View the org chart

Register to receive your alert

Report an error